| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031859388 |
Resistant |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.007510093 |
Sensitive |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009296932 |
Sensitive |
